INTRODUCTION
L-Arginine-derived nitric oxide (NO) is a mediator produced in mammalian cells by two types of NO synthase: a constitutively expressed type, which releases small amounts of NO required for physiological functions, and an inducible type, responsible for a sustained large output of NO, which, beyond a certain threshold, is potentially toxic (see refs. [1] and [2] for reviews). The NO produced in large amounts by the inducible form of NO synthase plays a multifunctional and somewhat paradoxical part in the immune system. Indeed, it behaves like an effector molecule of macrophage and hepatocyte cytotoxicity against intracellular pathogens [3] [4] [5] [6] , like a mediator of immunosuppression [7] [8] [9] and like a pathogenic factor in autoimmunity [10] . Therefore the biosynthesis and dissemination of such a reactive molecule necessarily requires stringent homoeostatic control. It is known from in vitro and in vivo experiments that NO biosynthesis is differently affected by different cytokines. Thus interferon y (IFN-y), interleukins 1 and 2 and tumour necrosis factor (TNF) all enhance production of the inducible type of NO synthase [11] [12] [13] [14] , whereas transforming growth factor and interleukins 8 and 10 have all been reported to reduce it [14] [15] [16] [17] . Consequently, a challenging issue in this field is to achieve control of highoutput NO synthase activity without inhibiting constitutive NO synthase activity. However, it appears that the catalytic mechanisms of the two types of enzyme are too similar to envisage the use of selective inhibitors for the high-output NO synthase. The signalling pathway that triggers high-output NO synthase activity has so far been little investigated and not much information is available about the induction on NO synthase gene transcription. Yet the identification of this pathway may make it possible to nicotinamide prevents expression of NO synthase mRNA in IFN-y-and LPS-stimulated cells. Nicotinamide was also found to inhibit other macrophage functions expressed in response to IFN-y, i.e. tumour necrosis factor secretion and the expression of the Ia antigen of the major histocompatibility complex. Analysis of the pattern of ADP-ribosylated proteins revealed that nicotinamide as well as cholera toxin prevented the ADPribosylation of a 107-117 kDa protein found constitutively ADPribosylated in stimulated and non-stimulated macrophage extracts. Together, our results indicate ADP-ribosylation as a crucial point of the signalling pathway which leads to NO synthase mRNA induction.
define a better way of preventing the harmful effects of excessive NO release.
The inducible NO synthase prototype has been isolated from the RAW 264.7 macrophage cell line [18, 19] , after stimulation with IFN-y and lipopolysaccharide (LPS) (both major macrophage activators), and its cDNA has been cloned in this cell line by several laboratories [20] [21] [22] . In the present study, we investigated the possibility of modulating the transductional events involved in NO synthase induction in RAW 264.7 macrophages.
As poly(ADP-ribosyl)ation has been reported to be involved in the expression of certain IFN-y-inducible genes [23, 24] , we decided to explore the question of whether inhibitors of ADPribosylation inhibit the induction of NO synthase activity in RAW 264.7 cells after their stimulation by IFN-y and LPS. We found that nicotinamide inhibited nitrite synthesis in these cells by preventing NO synthase mRNA induction, without inhibiting NO synthase activity. Two other important macrophage functions induced by IFN-y, i.e. TNF secretion and the expression of major histocompatibility complex (MHC) Class II, were also prevented by nicotinamide.
MATERIALS AND METHODS
Media and reagents Dulbecco's modified Eagle's medium (DMEM) and lowendotoxin fetal bovine serum (FBS) were obtained from Gibco Laboratories (Paisley, Scotland, U.K.). Murine recombinant IFN-y (specific activity 2 x 107 units/mg) and murine recombinant TNF-x (specific activity 3 x 107 units/mg) were from Genentech (South San Francisco, CA, U.S.A.) and were kindly provided by Dr Preparation of soluble extracts and NO synthase activity determination RAW 264.7 cells were activated by incubation for 15 h with 100 units/ml IFN-y, alone or with 10 ng/ml LPS. At the end of incubation, RAW 264.7 cell monolayers were washed and scraped off the culture dishes in PBS. Cells were resuspended at a density of 25 x 106/ml in 10 mM Tris/HCl, pH 7.5, containing the protease inhibitors, aprotinin (5 pg/ml), pepstatin (5 pg/ml), soya-bean trypsin inhibitor (10 pug/ml) and phenylmethanesulphonyl fluoride (0.1 mM). Soluble extracts were prepared as previously described [26] ; briefly, cell suspensions were sonicated in an ice bath with two bursts of 10 s (maximum power 40 %) with a Vibra Cell sonifier (Bioblock Scientific, Illkirch, France). The lysates were centrifuged for 20 min at 150000 g and 4°C in a TL100 ultracentrifuge (Beckman Instruments). Portions of the supernatants were immediately frozen at -80°C and stored until use. NO synthase activity was determined as previously described [25] , by incubating soluble extracts for I h 30 min at 37°C with 2 mM L-arginine and 2 mM NADPH. Residual NADPH which interferes with Griess reagent was hydrolysed for 15 min at 37°C with 2.5 units/ml L-glutamate dehydrogenase, 25 mM a-oxoglutaric acid and 150 mM NH4C1. Nitrite levels were determined as described above, using the Griess reagent.
Cell induction and RNA extraction
Exponentially growing cells (1 x 106 cells/ml) were stimulated in fresh complete medium for 3-6 h at 37°C in the presence or absence of IFN-y (100 units/ml) with or without LPS (10 ng/ml). When indicated, nicotinamide (10 mM) was added 30 agarose-gel electrophoresis, transferred to Hybond N+ membrane (Amersham, Bucks., U.K.) and hybridized with 32P_ labelled cDNA probes under the conditions suggested by the supplier. NO synthase and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNAs were gifts from Dr. C. J. Lowenstein [22] and Dr. P. Fort [28] respectively. cDNA probes were labelled with [a-32P]dCTP by the random-primer method (BoehringerMannheim). Hybridization signals were visualized by autoradiography; filters were exposed to Hyperfilm-MP (Amersham) with intensifying screens at -70 'C. Ethidium bromide-stained gels and hybridizations with GAPDH cDNA probe were used as controls.
Measurement of TNF activity TNF activity was measured by the cytotoxic assay on L929 cells, in the presence of 1 ,ug/ml actinomycin D. After incubation at 37°C, the medium was removed and cells were stained with Crystal Violet, by a previously described procedure [29] . (Figure lb) . In control experiments, nicotinamide concentrations of up to 50 mM did not interfere with NO synthase activity.
LPS also induces NO synthesis in macrophages, both alos4 and in synergy with IFN-y [12, 15] . As shown in Figure 1(c) , nitrite production by RAW 264.7 cells treated with increasing doses of IFN-y, with or without LPS, was greatly reduced by nicotinamide. Nicotinamide also inhibited nitrite production by cells stimulated by LPS alone (not shown).
Taken together, these results imply that nicotinamide inhibited the induction of NO synthase activity.
Effect of nicotinamide on the expression of NO synthase mRNA in immuno-stimulated macrophages To further define the-effect of nicotinamide, we determined the level of NO synthase mRNA expression in RAW 264.7 cells. For this purpose, cells were treated with IFN-y and LPS in the presence or absence of nicotinamide, and total RNA was extracted after 3 or 6 h of incubation. Determination of the NO synthase mRNA level by Northern-blot analysis showed that this mRNA was not constitutively expressed, and that it was already detectable as early as 3 h after stimulation (Figure 2, lane  D) . When nicotinamide was present in the culture medium during cell activation, and RAW 264.7 cells were activated with IFN-y and LPS, little or no NO synthase mRNA was detected (Figure 2, lanes F and K) . When cells were activated with IFNy alone, only a faint band was detectable when the film was overexposed, and only after 6 h (not shown). When nicotinamide was added to cells together with-IFN-y, no mRNA was detected either (Figure 2, lane J) . IFN-y, with or without LPS or nicotinamide, did not modify the GAPDH mRNA level ( Figure  2) . Further, after 6 Total RNA (25 ,ug) from RAW 264.7 cells treated with the indicated inducers for 3 or 6 h were subjected to Northern-blot analysis. The blot was hybridized with an NO synthase probe, as described in the Materials and methods section. Hybridization with a GAPDH probe was performed on the same blot after NO synthase hybridization, without prior dehybridization. IFN-y is 100 units/ml; LPS, 10 ng/ml; nicotinamide, 10 mM. activated by IFN-y alone, weak TNF activity of 16-32 units/ml was detectable, but only after 15-18 h. Whatever the stimulant used, no TNF activity was detectable in the presence of nicotinamide. Nicotinamide (10 mM) did not inhibit lysis of L929 cells in the presence of TNF-a and actinomycin D.
We then explored the question of whether prevention of TNF secretion by nicotinamide is responsible for inhibition of NO synthase induction. For this purpose, we added exogenous TNF to RAW 264.7 cells in an attempt to counteract the blockade by nicotinamide of nitrite synthesis on stimulation by IFN-y and LPS ( Table 2) . As expected, TNF-a alone was unable to induce nitrite synthesis, but synergized with IFN-y in this respect, in agreement with previous results [1 1, 12] . However, the addition of TNF-a to the stimulated cells did not avoid the inhibitory effect of nicotinamide on nitrite production. These results imply that the effects of nicotinamide action cannot be solely explained by its inhibition of TNF-a secretion.
Effect of nicotinamide on MHC Class-l1 expression in RAW 264. 
ADP-rlbosylation In RAW 264.7 cells
Nicotinamide has been reported to inhibit ADP-ribosylation, particularly poly(ADP-ribosyl)ation [32, 33] . Furthermore, Berton et al. [24] observed that protein poly(ADP-ribosyl)ation increased when macrophages were activated by IFN-y. Taken together with our results, these observations led us to suspect that nicotinamide might inhibit the poly(ADP-ribosyl)ation required in macrophages for the induction of NO synthase by IFN-y and LPS. Accordingly, RAW 264.7 cells were stimulated with IFN-y and LPS, and the cell-soluble extracts prepared after 6 h were analysed for in vitro ADP-ribosylation. Soluble extracts were incubated with [32P]NAD and parallel tests were conducted with nicotinamide and cholera or Bordetella pertussis toxins, both of which are known to catalyse ADP-ribosylation.
As shown in Figure 4 , autoradiography of the pattern of labelled products after SDS/PAGE revealed that, in both stimulated and unstimulated cells, two proteins were ADP-ribosylated: one of 37-39 kDa and the other of 107-117 kDa. The labelling of the 37-39 kDa protein was not modified by treatment with nicotinamide or toxins. However, the highly constitutive ADPribosylation of the 107-117 kDa polypeptide was inhibited by cholera toxin (Figure 4 , lanes B and F) and nicotinamide ( Figure 4 , lane H), but not by B. pertussis toxin (Figure 4 , lanes C and E). Inhibition by nicotinamide as well as the width of the band and the intensity of the labelling suggest that the 107-117 kDa protein was poly(ADP-ribosyl)ated.
DISCUSSION
Little is known about the signal-transduction pathway by which immunological stimuli induce NO synthase activity, although Severn et al. [34] recently indicated that protein kinase C may be involved in the induction of NO synthesis by IFN-y. Besides, Hauschildt et al. [35] showed that ADP-ribosylation inhibitors suppress nitrite production by LPS-stimulated macrophages. In the present work, we showed that nicotinamide and benzamide, two ADP-ribosylation inhibitors, prevented the induction, by IFN-y used alone or along with LPS, of NO synthase activity in RAW 264.7 macrophages. We found evidence that the prevention of this induction in turn inhibits NO synthesis, because there was almost no expression of NO synthase mRNA when RAW 264.7 cells were stimulated in the presence of nicotinamide. This action of nicotinamide does not seem to affect the overall RNA level, as no modification was observed in GAPDH mRNA expression, and incorporation of labelled uridine was not reduced by 10 mM nicotinamide within the time frame of our study.
These results agree with recent reports by Hauschildt et al. [35, 36] showing that nicotinamide suppressed nitrite production by LPS-stimulated macrophages and TNF-treated fibroblasts. However, according to these authors, the mechanism might involve the inhibition of the overall RNA synthesis which we found was not affected by nicotinamide in RAW 264.7 cells. These apparent contradictions can be explained by the fact that we only used 10 mM nicotinamide in this study, whereas Hauschildt et al. [35] observed a significant decrease in uridine uptake when using 20 mM nicotinamide and above. It is worthy of note that macrophages produce TNF in response to IFN-y and/or LPS, and we previously showed that anti-TNF antibodies prevent, at least in part, the production of nitrite by activated macrophages [11] . Endogenous TNF thus plays an important part in macrophage NO synthase induction. This feature is in keeping with the fact that exogenous TNF did not exhibit any additive effect to that of IFN-y and LPS on nitrite production. Hauschildt et al. [36] further showed that nicotinamide inhibits nitrite production by TNF-stimulated L929 fibroblasts. Here therefore we explored the possibility that the action of nicotinamide is mediated by the inhibition of TNF secretion. Our results indicate that, although nicotinamide inhibited the TNF secretion induced by IFN-y and LPS, the addition of exogenous TNF-a failed to bypass this blockade. Accordingly, inhibition of endogenous production of TNF by stimulated macrophages does not seem to be primarily responsible for the effects of nicotinamide on NO synthase induction. Our results rather support the hypothesis that nicotinamide targets intracellular messenger(s) involved in signal transduction. Nicotinamide is an inhibitor of ADP-ribosylation, and more specifically of poly(ADP-ribose) polymerase (PARP) [32, 33] [37] , platelets [38] , erythrocytes [39] and hepatocytes [40] . Note that NO enhances the endogenous ADP-ribosylation of GAPDH, which leads to inhibition of its enzyme activity [38, 40] . We observed here that the 37-39 kDa proteisi which was ADP-ribosylated in RAW 264.7 cells had the same characteristics as that described in platelets and neurons [41, 42] [43, 44] , although this enzyme activity has also been found in extranuclear compartments [43] . PARP plays a role in various processes, including DNA repair, differentiation and gene expression [44] . When activated, it converts itself into a protein carrying multiple ADP-ribose polymers, whereas nicotinamide and aminobenzamide respectively inhibit its activity [32, 43] and its autopoly(ADP-ribosyl)ation [45] . Recently, Martinez et al. [46] showed that PARP is mono(ADP-ribosyl)ated in the DNAbinding domain by a reaction catalysed by cholera toxin. Consequently, as suggested by the authors, it is reasonable to expect that this biochemical modification could lead to inhibition of PARP activity including its autopoly(ADP-ribosyl)ation. Even though the following hypothesis remains to be demonstrated experimentally, it is tempting to speculate that the 107-117 kDa polypeptide, which was ADP-ribosylated in RAW 264.7 macrophages and sensitive to both cholera toxin and nicotinamide, is in fact PARP. Our findings and these considerations allow us to hypothesize that nicotinamide might interfere with the intracellular signalling pathway involved in NO synthase induction by inhibiting PARP activity.
In conclusion, our results shed light on the transductional mechanism involved in NO synthase transcription and allow us to propose that the down-modulation of ADP-ribosylation might help to control excess NO production in certain pathological situations.
Note added in proof (received 4 November 1993) After this paper was accepted for publication, McDonald and Moss [47] reported that ADP-ribosylation of GAPDH is actually an NAD+ linkage.
